Abeona Therapeutics (ABEO) Tops Q1 EPS by 13c

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.24), $0.13 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Qualcomm CFO: have an opportunity to scale our annual revenue to $100 billion
• Bain to acquire a majority stake in Volkswagen's Everllence - FT